Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 3 (2006), Issue 11 (November)

1. Increased T cell recruitment to the CNS after amyloid beta 1-42 immunization in Alzheimer's mice overproducing transforming growth factor-beta 1.
   J Neurosci, 26(44): 11437-41. [Abstract] [Full-text]
2. An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid.
   Neurosci Lett, 409(3): 215-9. [Abstract] [Full-text]
3. Association analysis of NAD(P)H:quinone oxidoreductase gene 609 C/T polymorphism with Alzheimer's disease.
   Neurosci Lett, 409(3): 179-81. [Abstract] [Full-text]
4. Posture recognition in Alzheimer's disease.
   Brain Cogn, 62(3): 241-5. [Abstract] [Full-text]
5. Ideational action impairments in Alzheimer's disease.
   Brain Cogn, 62(3): 198-205. [Abstract] [Full-text]
6. Altered lymphocyte distribution in Alzheimer's disease.
   J Psychiatr Res, 41(1): 174-8. [Abstract] [Full-text]
7. Improving caregiver well-being delays nursing home placement of patients with Alzheimer disease.
   Neurology, 67(9): 1592-9. [Abstract] [Full-text]
8. Memory complaints are related to Alzheimer disease pathology in older persons.
   Neurology, 67(9): 1581-5. [Abstract] [Full-text]
9. Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease.
   Neurology, 67(9): 1575-80. [Abstract] [Full-text]
10. Same causes, same cures.
    Biochem Biophys Res Commun, 351(3): 578-81. [Abstract] [Full-text]
11. Detection of circulating antibodies against tau protein in its unphosphorylated and in its neurofibrillary tangles-related phosphorylated state in Alzheimer's disease and healthy subjects.
    Neurosci Lett, 410(2): 90-3. [Abstract] [Full-text]
12. Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice.
    J Neurosci, 26(46): 11923-8. [Abstract] [Full-text]
13. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.
    Neurobiol Dis, 24(3): 516-24. [Abstract] [Full-text]
14. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease.
    Neurobiol Dis, 24(3): 506-15. [Abstract] [Full-text]
15. Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease.
    Trends Pharmacol Sci, 27(12): 619-25. [Abstract] [Full-text]
16. Myocyte enhancing factor-2A in Alzheimer's disease: genetic analysis and association with MEF2A-polymorphisms.
    Neurosci Lett, 411(1): 47-51. [Abstract] [Full-text]
17. Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice.
    J Comp Neurol, 500(2): 311-21. [Abstract] [Full-text]
18. Alzheimer's disease and type 2 diabetes mellitus: the cholinesterase connection?
    Lipids Health Dis, 5: 28. [Abstract] [Full-text]
19. Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains.
    Neurobiol Aging, 28(1): 29-41. [Abstract] [Full-text]
20. Atrophy rates of the cingulate gyrus and hippocampus in AD and FTLD.
    Neurobiol Aging, 28(1): 20-8. [Abstract] [Full-text]
21. PIN1 promoter polymorphisms are associated with Alzheimer's disease.
    Neurobiol Aging, 28(1): 69-74. [Abstract] [Full-text]
22. The LDLR locus in Alzheimer's disease: a family-based study and meta-analysis of case-control data.
    Neurobiol Aging, 28(1): 18.e1-4. [Abstract] [Full-text]
23. Tau protein abnormalities associated with the progression of alzheimer disease type dementia.
    Neurobiol Aging, 28(1): 1-7. [Abstract] [Full-text]
24. Increased cholesterol in Abeta-positive nerve terminals from Alzheimer's disease cortex.
    Neurobiol Aging, 28(1): 8-17. [Abstract] [Full-text]
25. Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging.
    Neurology, 67(10): 1852-4. [Abstract] [Full-text]
26. A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease.
    Neurology, 67(10): 1757-63. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.